Quality Innovation Simplicity
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.
Spineart is a pioneer in its field, having introduced unique technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.
In every enhancement, Spineart is relentlessly driven by the same philosophy: Quality, Innovation, Simplicity.
Please visit www.spineart.com for more information.
Brands: ROMEO®2, ROMEO®2 LC, ROMEO®2 MIS, ROMEO®2 PAD, OTELO® LL, JULIET® Ti LL, JULIET® Ti TL, JULIET® Ti PO/OL, SCARLET®AL‐T, SCARLET®AC‐T, TRYPTIK® CA, TRYPTIK® CC, TRYPTIK®2 C-Plate, PERLA®, CURE, TALOS®
SPINEART announces the acquisition of Atlanta-based Meditech Spine LLC.
The companies anticipate significant synergies between the two organizations. As part of the transaction, Meditech Spine’s co-founder and chief executive officer, Eric Flickinger, will join SPINEART’s senior management team in the US.
Meditech manufactures and markets a portfolio of sterile-packed, barcoded CURE plates and TALOS PEEK-HA cages in the US. SPINEART manufactures and markets a comprehensive portfolio of sterile-packed, barcoded spinal posterior fixations, 3D-printed Ti-LIFE cages, artificial disc prosthesis and biologics in more than 50 countries.
SPINEART announces over 1,000 patients treated with SCARLET® AL-T, its ALIF system launched in 2019, in the USA. The implant was developed using the company’s flagship Ti-LIFE Technology, a titanium bone-like structure that supports bone cell adhesion and allows for bone ingrowth.
A number of design features make SCARLET® AL-T unique: the 3D printed cages feature tunnels which prevent screw misalignment, the screws are designed with a triple lead and threaded end-tip, eliminating the need to drill or awl, and the screw anti-backout system is both tactile and visual.
The results of an in-vivo animal study will be presented by Dr J. Laratta as an abstract at the 2020 North American Spine Society virtual meeting.
Spineart completed an in vivo study on sheep to evaluate its proprietary Ti-LIFE Technology under physiological conditions. At one spinal level, Ti-LIFE cages were implanted without bone graft or biological materials. At another spinal level, PEEK cages were implanted with morselized iliac crest autograft. The Ti-LIFE interbody cages displayed quick and effective osteointegration after only 4 weeks of implantation, in contrast to the PEEK cages which exhibited no osteointegration.
Ti-LIFE structures throughout the endplates are porous and provide primary stability. CT and mCT scans showed no osteolysis surrounding the Ti-LIFE cages, clearly displaying bone growth within the trabecular structure of the cages allowing for optimal primary stability. Formation of bone bridges within the cages’ graft windows was also detected. Histological sections revealed the triggering of osteogenesis through endochondral and lamellar ossification processes within the cage. In contrast, the PEEK cages exhibited peripheral osteolysis and no osteogenesis.
Ti-LIFE Technology is an enhanced algorithm for additive manufacturing of titanium cages resulting in structures with a bone-like matrix. Ti-LIFE structures have an average pore diameter and overall porosity similar to trabecular bone, which may enable cell colonization and promote bone ingrowth. Decreased cage density allows for optimal visualization on CT, X-ray and MRI.